March 3, 2026
Headlines

Beyond The Numbers: 8 Analysts Discuss Health Catalyst Stock

Sumain Faisal01 mins

Latest Ratings for HCAT

Date Firm Action From To
Mar 2022 Piper Sandler Maintains Overweight
Mar 2022 Raymond James Maintains Strong Buy
Mar 2022 Canaccord Genuity Maintains Buy

View More Analyst Ratings for HCAT

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News